0000899243-22-014962.txt : 20220418 0000899243-22-014962.hdr.sgml : 20220418 20220418160519 ACCESSION NUMBER: 0000899243-22-014962 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220414 FILED AS OF DATE: 20220418 DATE AS OF CHANGE: 20220418 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lee Yuchun CENTRAL INDEX KEY: 0001334365 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 22832185 MAIL ADDRESS: STREET 1: 170 TRACER LA. CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-04-14 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001334365 Lee Yuchun C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 1 0 0 0 Common Stock 2022-04-14 4 M 0 2000 81.54 A 3875 D Common Stock 2022-04-14 4 S 0 948 287.87 D 2927 D Common Stock 2022-04-14 4 S 0 252 288.92 D 2675 D Common Stock 2022-04-14 4 S 0 400 289.84 D 2275 D Common Stock 2022-04-14 4 S 0 400 291.18 D 1875 D Stock Option (Right to Buy) 81.54 2022-04-14 4 M 0 2000 0.00 D 2023-05-31 Common Stock 2000 2000 D Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $287.87 (range $287.49 to $288.26). Open market sales reported on this line occurred at a weighted average price of $288.92 (range $288.51 to $289.24). Open market sales reported on this line occurred at a weighted average price of $289.84 (range $289.69 to $289.96). Open market sales reported on this line occurred at a weighted average price of $291.18 (range $290.80 to $291.64). Fully vested. /s/ Sabrina Yohai, Attorney-in-Fact 2022-04-18